Evidence map›Paper›PMID 40502760›Full record

ArticleResearch square2025

Fatty Acid Oxidation Fuels Mitochondrial Respiration to Drive Epidermal Stem Cell Fate and Barrier Regeneration.

Anna Mandinova, Kristina Todorova, Stefano Sol, Fabiana Boncimino, Andrea Clocchiatti, Kazuki Takagaki, Enkhtuul Gantumur, Mihaela Ruseva, Meaghan Cadieux, Michelle Liu and 5 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Anna MandinovaMassachusetts General Hospital, Harvard Medical School.ORCID 0000-0001-9273-0972
Kristina TodorovaMassachusetts General Hospital, Harvard Medical School.
Stefano SolMassachusetts General Hospital and Harvard Medical School.ORCID 0000-0003-2576-0156
Fabiana BonciminoMassachusetts General Hospital, Harvard Medical School.
Andrea ClocchiattiMassachusetts General Hospital, Harvard Medical School.
Kazuki TakagakiMassachusetts General Hospital, Harvard Medical School.ORCID 0000-0002-8153-8077
Enkhtuul GantumurMassachusetts General Hospital, Harvard Medical School.
Mihaela RusevaMassachusetts General Hospital, Harvard Medical School.
Meaghan CadieuxMassachusetts General Hospital, Harvard Medical School.
Michelle LiuMassachusetts General Hospital, Harvard Medical School.
Victor NeelMassachusetts General Hospital, Harvard Medical School.
Amy ColwellMassachusetts General Hospital, Harvard Medical School.
Christine LianBrigham and Women's Hospital, Harvard Medical School.
George MurphyBrigham and Women's Hospital, Harvard Medical School.
Peter CarmelietVIB Center for Cancer Biology.ORCID 0000-0001-7961-1821

Funding

Stem Cell Integral Membrane Transporter ABCB5 and Dermal RegenerationP01AG071463 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Markus H. Frank · 2022 to 2026
$13.6M
NIA NIH HHS P01 AG071463
6 · The paper itself

Abstract

The skin's barrier function relies on the epidermis, whose structural integrity is maintained by basal stem cells that continuously renew and differentiate to form the multilayered epidermal architecture. Disruptions in epidermal differentiation underlie numerous hyperproliferative and inflammatory skin disorders. While transcriptional and epigenetic mechanisms are known to regulate the late stages of this process, the molecular events driving the early commitment to differentiation remain elusive. Here, we reveal that early mitochondrial reprogramming, characterized by the activation of oxidative phosphorylation (OXPHOS), is a critical determinant of differentiation initiation. Our findings identify fatty acid oxidation (FAO) as the primary metabolic pathway fueling OXPHOS during this process. Pharmacological and genetic inhibition of FAO, both in vitro and in vivo, disrupts differentiation and compromises the regeneration of the epidermal barrier, causing defective responses to physical insults. Mechanistically, FAO enables ATP production in committed epidermal cells to support the high energy demand of the differentiation process, establishing a direct link between lipid metabolism and epidermal homeostasis. These results uncover a previously unrecognized role for metabolic reprogramming in epidermal stem cell fate and highlight FAO as a novel target for therapeutic interventions to restore barrier function in pathological conditions.

Indexed as

Epidermal Stem CellsFatty Acid OxidationMetabolismMitochondrial RespirationStem Cell Differentiation

Identifiers

PMID40502760
PMCPMC12155225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.